The BalancedInvestor Club

ALVOW Market Analysis

Overview

Fundamentals

P/E ratio—
EPS (TTM)—-58.4% YoY
Profit margin4.7%
Market cap—

Valuation

Forward P/E
—
PEG ratio
—
P/B
—
P/S (TTM)
—
EV/EBITDA
—

Profitability & growth

ROE (TTM)
0.0%
Operating margin
33.8%
Revenue growth YoY
10.1%
Dividend yield
—
Beta
0.25

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Alvotech Warrant

Alvotech Holdings SA, develops and manufactures biosimilars for global markets. The company is headquartered in Iceland.

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
9, RUE DE BITBOURG, LUXEMBOURG
Fiscal year end
December
Latest quarter
Dec 31, 2025
Shares outstanding$0
52W high$2.98
52W low$0.15

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer